Small-cell lung cancer (SCLC) is an aggressive and fast-growing type of lung cancer that is commonly caused by smoking. In this video series, Benjamin Cooper, MD, sits down with Joshua Sabari, MD, and Rajwanth Veluswamy, MD, MSCR, to discuss the diagnostic differences between small cell and non-small cell lung cancers (NSCLC), as well as current and future treatment approaches for SCLC.
The panel reviews the steps taken during a patient’s initial evaluation for MCL, risk stratification in order to determine therapy options, and various options and benefits for testing.
Dr. Cooper reports a relationship with IBA.
Dr. Sabari has no financial disclosures to report.
Dr. Veluswamy reports relationships with AstraZeneca, Bristol-Myers Squibb, Merck, and Onconova.